Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Tingley Whittemore, holds the title of Chief Medical Officer at Tenaya Therapeutics, Inc..
On 2026-11-17, the insider transacted 3,223 shares.The shares were transacted at a weighted average price of $0.32 per share, resulting in a total market-relevant value of $1K.
Tingley Whittemore (Chief Medical Officer) sold $1K of $TNYA
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.